InsidersTradesSigma
Browse the full record of transactions filed by Aberman Zami, Director. Officer active across 1 companies, notably Pluristem Therapeutics INC. Aggregated, 1 filings have been published. Total volume traded: €127k. The latest transaction was disclosed on 10 February 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Aberman Zami is a Director at PLURISTEM THERAPEUTICS INC. In this role, he participates in the strategic direction of the company and in making important decisions. His commitment to innovation and research is vital for PLURISTEM THERAPEUTICS INC.